why choose us

First received: December 03, 2024

Clinical Trial: ALN-APOC3 in Adult Participants With Dyslipidemia

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dyslipidemia

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALN-APOC3 in Adult Participants With Dyslipidemia

Brief Summary: This study is researching an experimental drug called ALN-APOC3 (called "study drug").The study is focused on participants who have dyslipidemia (abnormal amounts of fats in the blood, including triglycerides and cholesterol), but who are otherwise healthy.The aim of the study is to see how safe and effective the study drug is.The study is looking at several other research questions, including:What side effects may happen from taking the study drugHow much study drug is in the blood at different timesHow…

Read more